The PC-12 cells were plated at a density of 3×104 cells/well in a 6-well plate placed on cover glass and were stabilized for 24 hours. The cells were incubated and treated according to the experimental schedule for 5 days. PC-12 cells were placed on ice and washed using PBS. The cells were dislodged using a cell scraper and pipetted into microcentrifuge tubes. They were centrifuged at 1,500 rpm for 5 minutes and the supernatant was discarded. Cells were lysed in mammalian tissue lysis/extraction reagent including protease inhibitor. Proteins were quantified using the bicinchoninic acid protein assay kit. Samples were prepared in 1×sodium dodecyl sulfate (SDS) sample buffer (50 mM Tris pH 6.8, 2% SDS, 10% glycerol, 50 mM dithiothreitol, and 0.01% bromophenol blue). Proteins were separated in 12% SDS-PAGE and transferred onto a polyvinylidene fluoride membrane. After blocking the membrane with 5% skim milk in Tris-buffered saline and Tween 20 at room temperature for 60 minutes, the membrane was incubated and immunoblotted with anti-caspase-3 (1:1,000), anti-cleaved caspase-3 (1:1,000), anti-Bcl-2 (1:1,000), anti-Akt (1:1,000), anti-phospho-Akt (Ser473, 1:1,000), and anti-α-tubulin (1:1,000) at 4℃ overnight. The biotinylated anti-mouse or anti-rabbit immunoglobulin G secondary antibodies were conjugated and were applied for 1 hour at room temperature. The membrane was developed by the alkaline phosphatase-conjugated development kit (Bio-Rad, Hercules, CA, USA). Developed protein bands were quantified by Multi Gauge version 2.2 program (Fuji photo film, Tokyo, Japan). α-Tubulin served as an internal control.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.